Rheumatology Flashcards

1
Q

Describe the clinical features of dermatomyositis and polymyositis

A

Causes
- autoimmune condition
> most common in women 50-70.

  • paraneoplastic disease
    > ovarian, breast and lung tumours are the most common underlying cancers
  • associated with connective tissue disorder

Clinical features
> inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions

> polymyositis is a variant of the disease where skin manifestations are not prominent

Skin features
- photosensitive macular rash over back and shoulder “shawl sign”
- heliotrope rash in the periorbital region
- Gottron’s papules - roughened red papules over extensor surfaces of fingers
- ‘mechanic’s hands’: extremely dry and scaly hands with linear ‘cracks’ on the palmar and lateral aspects of the fingers
- nail fold capillary dilatation

Other features
- proximal muscle weakness +/- tenderness
- Raynaud’s
- respiratory muscle weakness
- interstitial lung disease: e.g. fibrosing alveolitis or organising pneumonia
- dysphagia, dysphonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the clinical features of sarcoidosis

A

Characterised by non-necrotising granulomas in many organs

> Affects young adults; more common in people of African or Scandinavian heritage

Presentation
> Respiratory symptoms: non-productive dyspnoea or with abnormalities on CXR
> Bilateral hilar lymphadenopathy
> facial palsy, parotid enlargement
> uveitis, conjunctivitis, optic neuritis
> Erythema nodosum
> swinging fever
> polyarthralgia
> non-productive cough
> weight loss
> lupus pernio
> hypercalcaemia (may cause kidney stones, nephrocalcinosis)
> CNS involvement: diabetes insipidus, encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the diagnosis and management of sarcoidosis

A

Diagnosis
> raised ACE, raised serum calcium

> Transbronchial biopsy: non-caseating granulomas

> LFTs: may be liver nodules, cirrhosis & cholestasis

> ECG: if heart involvement may be bundle branch block

Management
- Asymptomatic - nothing
- indications for steroid treatment with prednisolone
> symptomatic and CXR stage 2 or 3
> hypercalcaemia
> neuro, eye or heart involvement
- methotrexate second-line
- lung transplant if severe pulmonary disease (pulmonary fibrosis, pulmonary hypertension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the treatment for rheumatoid arthritis (RA)

A

Newly diagnosed active RA: methotrexate + short course of oral prednisolone

> can also used other DMARDs such as sulfasalazine, leflunomide, hydroxychloroquine

Flares: oral or intramuscular corticosteroids e.g. methylprednisolone

TNF-inhibitors if inadequate response to at least 2 DMARDs
> etanercept, infliximab, adalimumab, rituximab, abatacept

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the clinical features of SLE

A

Clinical features
> photosensitive butterfly (malar) rash across nose and cheeks
> Arthralgia, myalgia
> dry cough, shortness of breath
> pleuritic chest pain
> serositits: pericarditis, pleuritis
> raynaud’s
> mouth ulcers, hair loss
> systemic symptoms: fatigue, weight loss, fever, lymphadenopathy
> oedema in lupus nephritis

investigations
- Positive antinuclear antibody (ANA)
- anti-dsDNA: elevated
- C3/C4 complement: decreased
- anaemia / thrombocytopenia / leukopenia
- CRP/ESR

risk factors: female, young-middle age adults, asian/african/hispanic/caribbean ethnicity

> associated with antiphospholipid syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the management of gout

A

Gout is caused by chronic hyperuricaemia (uric acid > 450 µmol/l)

Acute management
- NSAIDs or colchicine are first-line
> avoid NSAIDs in anticoagulated elderly due to risk of GI haemorrhage OR in CKD

  • steroids e.g. prednisolone

Indications for urate-lowering therapy (ULT) - all patients at least 2 weeks after their first attack of gout has settled

  • allopurinol is first-line
    > NSAID or colchicine cover should be added when starting allopurinol
    > increase until urate is below 300 micromol/L
  • second-line agent is febuxostat (also a xanthine oxidase inhibitor)

colchicine has GI side-effects like diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis)

A

ANCA associated small-medium vessel vasculitis.

Features
- severe asthma
- paranasal sinusitis
- allergic rhinitis
- mononeuritis multiplex
- renal involvement

investigations
- blood eosinophilia (e.g. > 10%)
- pANCA positive in 60%

Leukotriene receptor antagonists may precipitate the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe polymyalgia rheumatica and its treatment

A

clinical features
> pain and stiffness in shoulders (radiating to upper arm and elbow), pelvic girdle (radiating to thighs) and neck
> pain worse in the morning or after rest/inactivity
> systemic symptoms: fever, weight loss, fatigue
> muscle tenderness
> carpal tunnel syndrome
> peripheral oedema

risk factors: female, age >50, GCA, Northern European origin

Diagnosis: ESR and CRP raised (may be normal)
> CK is normal

Management
- oral prednisolone (initially 15mg but taper as time goes on)
- 2nd line: methotrexate, tocilizumab, anti-TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe pseudogout

A

microcrystal synovitis caused by deposition of calcium pyrophosphate crystals in the synovium

risk factors
- increasing age
- haemochromatosis
- hyperparathyroidism
- low magnesium, low phosphate
- acromegaly, Wilson’s disease

joint aspiration: weakly-positively birefringent rhomboid-shaped crystals

knee, wrist and shoulders most commonly affected

x-ray: chondrocalcinosis

Management
- aspiration of joint fluid, to exclude septic arthritis
- NSAIDs or intra-articular, intra-muscular or oral steroids as for gout
- colchicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe features of nerve root compression at the following levels
> L3
> L4
> L5
> S1

A

L3
> Sensory loss over anterior thigh
> Weak hip flexion, knee extension and hip adduction
> Reduced knee reflex
> Positive femoral stretch test

L4
> Sensory loss anterior knee and medial malleolus
> Weak knee extension and hip adduction
> Reduced knee reflex
> Positive femoral stretch test

L5
> Sensory loss dorsum of foot
> Weakness in foot and big toe dorsiflexion
> Reflexes intact
> Positive sciatic nerve stretch test

S1
> Sensory loss posterolateral aspect of leg and lateral aspect of foot
> Weakness in plantar flexion of foot
> Reduced ankle reflex
> Positive sciatic nerve stretch test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe Henoch Schonlein Purpura (HSP)

A

IgA vasculitis commonly affecting children

often triggered by URTI / gastroenteritis

features
- palpable purpuric rash over lower limbs and buttocks
- joint pain
- abdominal pain
- acute scrotum
- renal involvement (IgA nephritis)

management
- monitor BP and dipstick closely for renal involvement
- steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe polyarteritis nodosa

A

medium-vessel vasculitis

causes
- idiopathic
- secondary to infection e.g. Hep B

clinical features
- renal impairment
- hypertension
- tender erythematous skin nodules
- myocardial infarction
- stroke
- mesenteric arteritis causing intestinal symptoms

no positive immunology, based on imaging e.g. CT CAP

treatment: steroids, cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe Kawasaki disease

A

medium vessel vasculitis

affects children usually under 5

clinical features
- persistent high fever >5 days
- strawberry tongue
- widespread erythematous maculopapular rash
- desquamation of palms and soles
- bilateral non-purulent conjunctivitis
- cervical lymphadenopathy
- cracked lips

complication - coronary artery aneurysm

management
- high dose aspirin: reduce risk of thrombosis
- IV immunoglobulins: reduce risk of coronary artery aneurysms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe Takayasu’s arteritis

A

large vessel vasculitis - presents before age 40

affects aorta (aortitis) and its branches, can affect pulmonary arteries

vessels may swell and form aneurysms or become narrowed and blocked
> can reduce pulses in limbs

symptoms
- fatigue
- malaise
- muscle aches
- claudication symptoms

diagnosis - CT / MRI angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe the clinical features of gout

A

crystal arthropathy associated with chronically high uric acid levels

clinical features
- gouty tophi
- hot acutely swollen single painful joint
- often first MTP, first CMC, wrist

risk factors: male, family history, alcohol consumption, high purine diet, obesity

investigations
- high urate
- joint aspiration: needle-shaped negatively birefringent crystals (monosodium urate)

  • X-ray: no loss of joint space, lytic lesions, punched out erosions, sclerotic borders with overhanging edges
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe microscopic polyangiitis

A

small vessel vasculitis

associated with p-ANCA

clinical features
- glomerulonephritis
- haemoptysis: diffuse alveolar haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe Behcet’s syndrome

A

autoimmune small vessel vasculitis that targetese venules

classic triad
- oral ulcers
- genital ulcers
- anterior uveitis

more common in the eastern Mediterranean, more common in young men

associated with HLA B51

other features
- thrombophlebitis and deep vein thrombosis
- arthritis
- neurological involvement (e.g. aseptic meningitis)
- GI: abdo pain, diarrhoea, colitis
- erythema nodosum

Diagnosis
no definitive test
diagnosis based on clinical findings
positive pathergy test is suggestive (puncture site following needle prick becomes inflamed with small pustule forming)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe granulomatosis with polyangiitis (GPA)

A

small vessel vasculitis associated with c-ANCA / PR3 antibodies

previously known as Wegener’s granulomatosis

features
- respiratory symptoms: cough, wheeze, haemoptysis
- saddle-shaped nose due to nasal bridge collapse
- sinusitis
- epistaxis
- hearing loss
- crescentic glomerulonephritis

management
- steroids
- rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe the clinical features of systemic sclerosis

A

causes hardened, sclerotic skin and other connective tissues

more common in females

limited cutaneous systemic sclerosis
- CREST syndrome: calcinosis, raynaud’s, esophageal dysmotility, sclerodactyly, telangiectasia

  • distal limb and face involvement
  • anti-centromere antibodies (mere, limited)

diffuse cutaneous systemic sclerosis
- CREST + systemic organ involvement
- scleroderma involves trunk and proximal limbs
- anti-scl-70 antibodies
- ILD and pulmonary arterial hypertension can be seen
- renal disease and hypertension can occur

scleroderma without internal organ involvement: tightening and fibrosis of skin, plaques (morphoea) or linea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe the clinical features, risk factors and diagnosis of osteoporosis

A

generalised skeletal disorder characterised by compromised bone strength and deterioration of bone quality, often leading to fragility fracture.

T-score: number of standard deviations above/below average bone density for healthy young adult

osteopaenia: T-score between -1.0 and -2.5

Diagnosis
- DXA scanning with a T-score ≤ -2.5
- fragility fractures present
- Frax tool
- check testosterone in men

Risk factors
> Post-menopausal women
> People over the age of 65
> People of caucasian / asian descent
> People with a slight body habitus
> steroid use

clinical features
- back pain
- loss of height or development of a “stoop” or “hump.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe Felty’s syndrome

A

RA, splenomegaly and low white cell count (neutropaenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the clinical features of reactive arthritis

A

sometimes called Reiter’s syndrome, seronegative spondyloarthropathy

linked with HLA-B27

features
- acute monoarthritis
- joint pain

often precipitated by gastroenteritis or STIs e.g. Chlamydia trachomatis, Neisseria gonorrhoea

associations
- anterior uveitis
- bilateral conjunctivitis
- urethritis

  • rash
    > keratoderma blennorrhagica: waxy yellow/brown papules on palms and soles)
    > circinate balanitis (painless vesicles on penis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

describe Still’s disease

A

also known as systemic onset juvenile idiopathic arthritis, can be adult onset if >16 years

rare systemic inflammatory disorder
> inflammatory polyarthritis
> high swinging fevers
> weight loss
> splenomegaly
> pleuritis and pericarditis
> transient salmon-pink maculopapular rash
> lymphadenopathy

investigations
- RF and ANA negative
- serum ferritin level of more than 1000 ng/ml is common in this condition

complication: macrophage activation syndrome

management
> NSAIDs
> steroids
> methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

describe the investigations, risk factors and scoring systems for RA

A

associated with HLA DR4/DR1

Investigations
- Rheumatoid factor (RF)
- Anti-cyclic citrullinated peptide antibody (anti-CCP)
- X-rays of hands and feet

X-rays
- juxta-articular osteoporosis (most common early feature)
- periarticular erosions
- soft tissue swelling: joint effusion, oedema, tenosynovitis
- loss of joint space

Risk factors:
> smoking
> positive family history
> female sex

Scoring system
> DAS28
> HAQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

describe joint aspirate results in
> rheumatoid arthritis
> septic arthritis

A

RA
- yellow colour, increased opacity
- 2000-50,000 leukocytes per microlitre
- gram staining is negative
- variable neutrophil count (PMNs)
- no crystals

Septic arthritis
- cloudy/opaque
- >50,000 leukocytes per microlitre
- gram staining is positive
- >90% neutrophils
- no crystals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe seronegative spondyloarthropathies and their common features

A

Spondyloarthropathies
- Ankylosing spondylitis
- Psoriatic arthritis
- Reactive arthritis
- Enteropathic arthritis (associated with IBD)

  • Associated with HLA B27
  • Rheumatoid factor negative (seronegative)

Features:
- Peripheral arthritis (asymmetrical)
- Sacroiliitis
- Enthesopathy: Achilles tendonitis, plantar fasciitis

  • Extra-articular manifestations:
    > eyes: uveitis
    > lungs: pulmonary fibrosis
    > amyloidosis
    > heart: aortic regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which medication should never be prescribed with methotrexate?

A

Trimethoprim or co-trimoxazole

> as this is an antimetabolite that inhibits dihydrofolate reductase, both drugs together can cause severe myelosuppression

28
Q

Describe the features of psoriatic arthritis

A

Patterns
> symmetric polyarthritis or asymmetrical oligoarthritis
> sacroiliitis
> DIP joint disease
> arthritis mutilans (severe deformity fingers/hand, ‘telescoping fingers’)

Other signs
> psoriatic skin lesions

> periarticular disease - tenosynovitis and soft tissue inflammation resulting in:
> enthesitis: inflammation at the site of tendon and ligament insertion e.g. Achilles tendonitis, plantar fascitis

> > tenosynovitis: typically of the flexor tendons of the hands

> > dactylitis: diffuse swelling of a finger or toe

> nail changes
> pitting
> onycholysis

29
Q

describe the investigations and management of psoriatic arthritis

A

Investigations
> X-ray: erosive changes and new bone formation, periostitis, ‘pencil-in-cup’ appearance, plantar spur

Management
- mild: NSAID
- moderate/severe: methotrexate

  • monoclonal antibodies e.g. ustekinumab (targets both IL-12 and IL-23) and secukinumab (targets IL-17)
  • apremilast: phosphodiesterase type-4 (PDE4) inhibitor
30
Q

describe the clinical features of ankylosing spondylitis

A

Clinical features:
- Lower back pain radiating to buttocks (worse with prolonged sitting)
- Young males
- Stiffness
- wakening from sleep, pain worse in the morning
- improvement with exercise
- limited forward flexion (Schober’s test): <5cm change
- occiput to wall distance (flesche test) reduced
- reduced chest expansion
- question mark spine: thoracic kyphosis and neck hyperextension)

  • Extra-articular features
    > anterior uveitis
    > AV node block
    > achilles tendonitis
    > atlanto-axial subluxation
    > apical lung fibrosis
    > aortic incompetence
    > amyloidosis
31
Q

describe the investigations and management of ankylosing spondylitis

A

Investigations
- RF negative
- HLA-B27 positive

  • SI joint and spine X-ray:
    > blurred margins of SI joints (sacroiliitis)
    > erosions of corners of vertebral bodies (Romanus lesions)
    > squaring of lumbar vertebrae
    > development of bony spurs (syndesmophytes)
    > calcification of spine ligaments (bamboo spine)
  • MRI whole spine and sacroiliac joints
  • CXR: apical fibrosis

Management
- NSAIDs
- Physiotherapy
- cDMARDs e.g. methotrexate if peripheral joint involvement
- bDMARDS if failure of NSAIDs and PT
> anti-TNF therapy if persistently high disease activity despite conventional treatment

32
Q

describe osteomalacia

A

defective bone mineralisation due to vitamin D deficiency
> known as rickets in children

symptoms
- fatigue
- bone pain
- proximal muscle weakness
- muscle aches
- pathological / abnormal fractures
- children:
> widening of joints
> “bow legs”, “knock knees”, “rachitic rosary”, craniotabes (delayed closure of sutures and frontal bossing), delayed teeth

biochemical features
- low vitamin D, low calcium, high PTH

treatment - supplementation with vitamin D3

33
Q

describe Paget’s disease

A

disease of increased bone turnover
> most commonly affects pelvis, then skull/spine, long bones of lower extremities

symptoms
- enlarged misshapen bones
- bone pain
- hearing loss (can affect ear bones)
- pathological fracture

X-ray features
- lytic and sclerotic lesions
- osteoporosis circumscripta: well-defined osteolytic lesions
- cotton wool appearance of skull

investigations
- biochemistry: high ALP, normal calcium
- isotope bone scan - detect metabolically active disease

may be transformation to Paget’s sarcoma, a type of osteosarcoma

management (if symptomatic)
- analgesia: NSAIDs
- bisphosphonates

34
Q

describe the investigations and management of reactive arthritis

A

investigations
- joint aspiration: exclude septic arthritis

management
- treatment of infectious trigger
- NSAIDs
- steroid injections
- systemic steroids if multiple joints affected
- recurrent: DMARDs, anti-TNFs

most cases resolve within 6 months

35
Q

Describe osteoarthritis, its X-ray changes and clinical features

A

commonly affected joints
- hip, knee
- CMC joint base of thumb
- DIP joints of hands
- lumbar and cervical spine

Clinical features
- Activity-related pain in weight-bearing joints that improves with rest
- Knee-locking
- Morning stiffness lasting under 30 minutes
- Joint effusions
- reduced internal rotation

X-ray changes of osteoarthritis (LOSS)
- Loss of joint space
- Osteophytes forming at joint margins
- Subchondral sclerosis
- Subchondral cysts

36
Q

Describe the management of osteoarthritis

A

Management
- topical NSAIDs first-line
- oral NSAIDs + PPI (avoid if taking aspirin)

  • do not offer paracetamol / weak opioids, unless infrequently for short-term pain relief
  • glucosamine and strong opioids are not recommended
  • non-pharmacological:
    > weight loss
    > therapeutic exercise e.g. swimming
    > walking aids for knee and hip OA
  • intra-articular steroid injections
  • if conservative methods fail then refer for joint replacement
37
Q

describe the clinical features of rheumatoid arthritis

A

inflammatory symmetrical distal arthritis due to autoimmune inflammation of synovium (synovitis)

clinical features
- morning stiffness lasting >30 minutes
- joint pain and swelling
- systemic symptoms: fatigue, weight loss, muscle aches and weakness

small joints of hands and feet most commonly affected
- PIP joints
- MCP joints
- wrist
- MTP joints

> large joints may also be affected as well as cervical spine

examination: tenderness and synovial thickening

38
Q

describe the hand deformities associated with advanced RA

A
  • Z-shaped deformity of thumb
  • ulnar deviation of fingers at MCP joints
  • swan-neck deformity: hyperextended PIP and flexed DIP
  • Boutonniere’s deformity: dyperextended DIP and flexed PIP
39
Q

list extra-articular manifestations of RA

A
  • scleritis / episcleritis
  • pulmonary fibrosis
  • anaemia of chronic disease
  • cardiovascular disease
  • carpal tunnel syndrome
  • sjogren’s syndrome
  • amyloidosis
  • lymphadenopathy
  • rheumatoid nodules
40
Q

list side-effects of the following medications
- methotrexate
- hydroxychloroquine
- leflunomide
- sulfasalzine
- anti-TNF medications
- rituximab

A

methotrexate
- bone marrow suppression and leukopaenia
- highly teratogenic

hydroxychloroquine
- retinal toxicity: bull’s eye retinopathy
- grey-blue skin pigmentation
- hair bleaching

leflunomide
- hypertension
- peripheral neuropathy

sulfasalazine
- orange urine
- male infertility

  • anti-TNF: reactivation of TB
  • rituximab: night sweats, thrombocytopaenia
41
Q

list complications of SLE

A
  • pericarditis
  • nephritis
  • neuropsychiatric SLE

lung
- pleuritis
- interstitial lung disease

42
Q

describe the management of SLE

A

Management
- First-line:
> Hydroxychloroquine
> NSAIDs
> steroids e.g. prednisolone

  • resistant or severe e.g. internal organ involvement e.g. renal, neuro, eye
    > DMARDS: mycophenolate mofetil, methotrexate, cyclophosphamide
    > biologics: rituximab, belimumab

> Sunblock for photosensitive rash

43
Q

describe discoid lupus erythematosus

A

autoimmune chronic skin condition

risk factors: women, dark skinned, smokers

associated with increased risk of developing SLE

clinical features
- dry, red, scaling lesions
- photosensitive
- scarring alopecia
- hypo/hyperpigmentation
- lesions on face, scalp and ears

  • skin lesions can progress to SCC

investigations: skin biopsy

management
- sun protection
- topical steroids
- intralesional steroid injections
- hydroxychloroquine

44
Q

describe the investigations and management of dermatomyositis and polymyositis

A

Investigations
- creatine kinase (CK)
- ANA positive
- anti-synthetase antibodies e.g.:
> Jo-1
>SRP
> anti-Mi-2

management
- steroids first-line
- DMARDs: methotrexate, azathioprine
- IV immunoglobulins
- biologics: infliximab, etanercept

45
Q

describe antiphospholipid syndrome

A

antiphospholipid antibodies
- anti-cardiolipin
- lupus anticoagulant
- anti-beta-2 glycoprotein I antibodies

complications
- VTE: DVT, PE
- arterial thrombosis: stroke, MI, renal thrombosis
- pregnancy complications: recurrent miscarriage, pre-eclampsia, stillbirth

catastrophic antiphospholipid syndrome: rare complication with rapid thrombosis affecting multiple organs over days

associations
- livedo reticularis: purple lace-like rash
- Libmann-Sacks endocarditis: non-bacterial with vegetations associated with SLE and antiphospholipid syndrome
- thrombocytopaenia

management
- primary thromboprophylaxis: daily low dose aspirin
- secondary thromboprophylaxis: long-term warfarin
- LMWH and aspirin in pregnancy to reduce risk

46
Q

describe Sjogren’s syndrome

A

autoimmune condition affecting exocrine glands e.g. lacrimal and salivary glands

clinical features
- dry eyes, mouth, vagina
- may cause joint pain and stiffness
- recurrent episodes of parotitis
- subclinical renal tubular acidosis

more common in middle aged women

investigations
- antibodies: anti-Ro, anti-La, RF positive
- Schirmer test: <10mm
- salivary gland biopsy

management
- artificial tears
- artificial saliva
- vaginal lubricant
- oral pilocarpine to stimulate tear and saliva production
- hydroxychloroquine if joint pain

complications
- pneumonia, bronchiectasis
- Non-Hodgkins lymphoma (increased risk)
- vasculitis

47
Q

describe the management of systemic sclerosis

A

Raynaud’s - avoid cold, nifedipine

Acid reflux - PPI

Sclerodactyly - emollients

Antihypertensives (ACEi) - hypertension and scleroderma renal crisis (beware of steroids)

Internal organ involvement
> DMARDs: methotrexate
> Biologics: rituximab

Digital ulceration: IV iloprost (prostaglandin)

Pulmonary hypertension - sildenafil (PDE-5 inhibitor), bosentan (endothelin receptor antagonist)

48
Q

describe Ehlers-Danlos syndrome

A

types

  • hypermobile: joint hypermobility, soft and stretchy skin
  • classical: severe joint hypermobility, joint pain, abnormal wound healing
    > patients prone to hernias, prolapses, mitral regurgitation, aortic root dilatation
  • vascular: AD
    > thin, translucent skin
    > sudden unexplained pain or bleeding
    > GI perforation, spontaneous pneumothorax
  • kyphoscoliotic: AR
    > poor muscle tone (hypotonia)
    > kyphoscoliosis
    > joint dislocation

assessed with Beighton score

management: PT/OT

49
Q

describe rheumatic fever

A

autoimmune condition triggered by streptococcus bacteria (usually strep pyogenes after tonsillitis)

presents 2-4 weeks after infection
- fever
- joint pain
- shortness of breath
- chorea
- nodules
- migratory arthritis
-pericarditis/myocarditis/endocarditis
> leads to pericardial rub, tachycardia/bradycardia, murmus like mitral stenosis, heart failure

  • skin: erythema marginatum, subcutaneous nodules

investigations
- throat swab
- Anti-streptococcal (ASO) antibody titres
- echo, ECG, CXR
- Jones criteria

management
- NSAIDs: joint pain
- aspirin and steroids: carditis
- prophylactic antibiotics

50
Q

describe drug-induced lupus

A

features
- arthralgia, myalgia
- skin (malar rash) and pulmonary involvement (pleurisy)

investigations
- ANA positive, dsDNA negative
- associated with antihistone antibodies

causes
- common: procainamide, hydralazine
- uncommon: isoniazid, minocycline, phenytoin

51
Q

describe chronic fatigue syndrome or myalgic encephalopathy

A

at least 3 months of disabling fatigue affecting mental and physical function >50% of the time

clinical features
- fatigue
- sleep problems: insomnia, hypersomnia
- muscle and/or joint pains
- headaches
- painful lymph nodes without enlargement
- sore throat
- cognitive dysfunction
- physical or mental exertion makes symptoms worse
- general malaise, dizziness, nausea, palpitations

Management
- energy management
- cognitive behavioural therapy

52
Q

describe osteochondritis dissecans

A

pathological process affecting the subchondral bone with secondary effects on the joint cartilage

affects children and young adults

clinical features
- knee pain and swelling, typically after exercise
- knee catching, locking and/or giving way
- feeling a painful ‘clunk’ when flexing or extending the knee

Signs:
- joint effusion
- tenderness on palpation of the articular cartilage

Investigations:
X-ray - subchondral crescent sign or loose bodies

53
Q

how long must patients wait after methotrexate treatment to conceive

A

6 months

54
Q

describe methotrexate-induced pneumonitis

A

clinical features
- cough
- dyspnoea
- fever
- scattered crepitations

55
Q

describe the management of osteoporosis following a fragility fracture

A

start alendronate without waiting for DEXA scan in patients >= 75 years

56
Q

describe the prevention of fragility fractures in bone metastases

A

prevention
- bisphosphonates and denosumab can be used to prevent pathological fractures in bone metastases
- if eGFR <30 denosumab is preferred

57
Q

describe growing pains

A

child complaining of pain in the legs with no obvious cause

aka benign idiopathic nocturnal limb pains of childhood

occur in the age range of 3-12 years

Features of growing pains
- never present at the start of the day after the child has woken
- no limp
- no limitation of physical activity
- systemically well
- normal physical examination
- motor milestones normal
- symptoms are often intermittent and worse after a day of vigorous activity

58
Q

describe the treatment of osteoporosis

A

management

  • calcium + vitamin D
  • bisphosphonates e.g. alendronic acid (oral), zolendronic acid (IV)

> side effects: nausea, oesophageal ulceration, osteonecrosis of the jaw
after 5 years of bisphosphonates re-assess 10 year fracture risk

  • strontium ranelate
  • raloxifene
  • denosumab
  • teriparatide
59
Q

describe rheumatic fever

A

complication of inadequately treated group A streptococcal pharyngitis (Streptococcus pyogenes) after 2-4 weeks

features
- recent sore throat

  • erythema marginatum
    > pink ring-shaped lesions on trunk
  • polyarthritis
  • carditis and valvulitis
  • Sydenham chorea: jerking movements of face and hands
  • murmur: mitral or aortic stenosis
  • subcutaneous nodules

management
- antibiotics: oral penicillin V
- anti-inflammatories: NSAIDs
- treat complications e.g. heart failure

60
Q

describe the different types of Ehlers-Danlos syndrome

A

group of genetic conditions involving defects in collagen

types
- classical: AD inheritance
> stretchy skin that feels soft and velvety
> severe joint hypermobility
> joint pain
> abnormal wound healing
> complications: hernias, aortic root dilatation, prolapses, mitral regurgitation

  • hypermobile: most common, least severe, AD inheritance
    > joint hypermobility
    > soft and stretchy skin
  • vascular: most severe and dangerous, AD inheritance
    > thin translucent skin
    > fragile blood vessels prone to rupture
    > complications: GI perforation, spontaneous pneumothorax
  • kyphoscoliotic: AR inheritance
    > hypotonia as a neonate and infant
    > kyphoscoliosis during growth
    > joint hypermobility; dislocations are common
61
Q

describe the clinical features of hypermobile Ehlers-Danlos syndrome

A

clinical features
- joint dislocations
- soft and stretchy skin
- stretch marks (striae)
- easy bruising, poor wound healing, bleeding
- chronic pain
- chronic fatigue
- headaches
- autonomic dysfunction e.g. POTS
- GORD
- abdo pain
- IBS
- menorrhagia, dysmenorrhoea
- premature rupture of membranes in pregnancy
- urinary incontinence
- pelvic organ prolapse
- TMJ dysfunction

62
Q

describe the investigations and management of hypermobile Ehlers-Danlos syndrome

A

investigations:

Beighton score
> place palms flat on floor with straight legs
> hyperextend elbows
> hyperextend knees
> bend thumb to touch forearm
> hyperextend little finger past 90 degrees

hypermobile EDS is a clinical diagnosis with Beighton score
> other types may require genetic testing

management: supportive

63
Q

describe juvenile idiopathic arthritis

A

types:
> systemic JIA

> polyarticular JIA
- 5 joints or more
- mild fever, anaemia, reduced growth
- seronegative (majority) and seropositive

> oligoarticular jIA
- 4 joints or more
- usually only affects one larger joint
- associated with chronic anterior uveitis
- signs of chronicity can include fixed flexion deformity, muscle wasting
- ANA positive but RF negative

> enthesitis-related arthritis
- HLA B27 positive
- signs of IBD or psoriasis
- anterior uveitis

> juvenile psoriatic arthritis

children with JIA must be monitored by ophthalmologist for chronic anterior uveitis which can cause blindness and is asymptomatic

64
Q

describe macrophage activation syndrome

A

severe activation of immune system with massive inflammatory response

features
- acutely unwell
- DIC
- anaemia
- thrombocytopaenia
- bleeding
- non-blanching rash

investigation: low ESR

65
Q

describe Marfan’s syndrome

A

AD connective tissue disorder caused by a defect in fibrillin-1

Features
- tall stature with long arm span
- high-arched palate
- arachnodactyly
- pectus excavatum
- pes planus
- scoliosis
- mitral valve prolapse
- blue sclera
- myopia
- dural ectasia

complications
- aortic dissection
- pneumothorax
- upwards lens dislocation